Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020-Asia-Pacific

1

Market Digest Aesthetic Lasers and Energy
Devices Market 2006 to 2020-Asia-Pacific

Published By GBI Research
Published November 2014
2
Description


GBI Research, the leading business intelligence
provider, has released its latest research, Type
2 Diabetes Therapeutics in Asia-Pacific Markets
to 2020 Increasing Uptake of Novel Drug Classes
to Drive Market Growth, which provides insights
into type 2 diabetes in the Asia-Pacific (APAC)
markets of China, India, Japan and Australia. The
report estimates the market size for 2013 and
provides a forecast until 2020, and covers
disease epidemiology, treatment algorithms, and
treatment use patterns. It also provides in-depth
analysis of the pipeline molecules, clinical
trial failure rates, and recent deals. The
report has been built using data and information
sourced from proprietary databases, primary and
secondary research and in-house analysis carried
out by GBI Researchs team of industry
experts. In 2013, the value of the type 2
diabetes therapeutics market in APAC countries
was an estimated 6.5 billion, and it is forecast
to grow at a Compound Annual Growth Rate (CAGR)
of 7.1 between 2013 and 2020 to 10.5 billion.
3
Description


Scope The report analyzes the treatment use
patterns, market characterization, pipeline
analysis and key licensing and co-development
deals of the type 2 diabetes in the APAC markets
of China, India, Japan, and Australia. It
includes A brief introduction to type 2
diabetes, including its pathophysiology,
etiology, diagnosis and treatment
algorithms. In-depth analysis of currently
marketed drugs for type 2 diabetes, including
analysis of their safety, efficacy, treatment
patterns, and strengths and weaknesses, as well
as a heat map comparing them in terms of safety
and efficacy
4
Description

Reasons to buy The report will enhance your
decision-making capability by allowing you to
- Assess the potential risk of future
developmental programs for type 2 diabetes
therapeutics, depending on the mechanism of
action, by taking into account the recorded
clinical trial failure rates Examine the growth
patterns expected for the type 2 diabetes market
over the forecast period and the countries that
are expected to contribute the most to this
growth, allowing you to devise a more effectively
tailored country strategy through an
understanding of key drivers and
barriers Accelerate and strengthen your market
position by identifying key companies for
strategic partnerships
5
Table of Contents

• 1 Table of Contents
• 2 Introduction
• 2.1 Disease Introduction
• 3 Marketed Products
• 4 Asthma Pipeline
• 4.1 Overview
• 4.2 Pipeline Analysis by Stage of
  Development, Molecule Type
• 4.3 Pipeline Analysis by Molecular Target
• 4.4 Asthma Clinical Trial Landscape
• 5 Market Forecast to 2020
• 5.1 Geographical Markets
• 5.2 Global Market

6
Table of Contents

• 6 Strategic Consolidations
• 6.1 Co-development Deals
• 6.1.1 Sepracor Enters into Co-Development
  Agreement
• 7 Appendix
• 7.1 All Pipeline Drugs by Phase of
  Development
• For inquiry, kindly contact at
• http//www.reportsandintelligence.com/enquire-abou
  t-report/176580
• To check table of contents of the research, Visit
  _at_ http//www.reportsandintelligence.com/digest-ae
  sthetic-lasers-and-energy-devices-2006-to-2020-asi
  a-pacific-market/table-of-contents

7

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/digest-aesth
etic-lasers-and-energy-devices-2006-to-2020-asia-p
acific-market
Stay With Us
TELEPHONE Direct 1 [phone] Toll Free
1 [phone]E-MAIL sales_at_reportsandintellig
ence.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States